{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T12:49:16Z","timestamp":1760014156847,"version":"3.37.3"},"reference-count":61,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","theclinics.com","pediatric.theclinics.com","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pediatric Clinics of North America"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1016\/j.pcl.2015.03.009","type":"journal-article","created":{"date-parts":[[2015,4,7]],"date-time":"2015-04-07T17:32:27Z","timestamp":1428427947000},"page":"787-798","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Ethical and Policy Issues in Newborn Screening of Children for Neurologic and Developmental Disorders"],"prefix":"10.1016","volume":"62","author":[{"given":"Lainie Friedman","family":"Ross","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"1997","author":"Koch","series-title":"Robert Guthrie: the PKU story: a crusade against mental retardation","key":"10.1016\/j.pcl.2015.03.009_bib1"},{"key":"10.1016\/j.pcl.2015.03.009_bib2","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1353\/pbm.1999.0032","article-title":"Contesting consent: the challenge to compulsory neonatal screening for PKU","volume":"42","author":"Paul","year":"1999","journal-title":"Perspect Biol Med"},{"year":"1975","author":"National Research Council","series-title":"Committee for the study of inborn errors of metabolism. Genetic screening: programs, principles and research","key":"10.1016\/j.pcl.2015.03.009_bib3"},{"key":"10.1016\/j.pcl.2015.03.009_bib4","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/BF01799385","article-title":"Tandem mass spectrometry: a new method for acylcarnitine profiling with potential for neonatal screening for inborn errors of metabolism","volume":"13","author":"Millington","year":"1990","journal-title":"J\u00a0Inherit Metab Dis"},{"issue":"Suppl 1","key":"10.1016\/j.pcl.2015.03.009_bib5","first-page":"1S","article-title":"Newborn screening: toward a uniform screening panel and system","volume":"8","author":"American College of Medical Genetics Newborn Screening Expert Group","year":"2006","journal-title":"Genet Med"},{"year":"1968","author":"Wilson","series-title":"Principles and practice of screening for disease. Public health papers 34","key":"10.1016\/j.pcl.2015.03.009_bib6"},{"year":"1994","series-title":"Assessing genetic risks: implications for health and social policy","key":"10.1016\/j.pcl.2015.03.009_bib7"},{"key":"10.1016\/j.pcl.2015.03.009_bib8","first-page":"1233","article-title":"American College of Medical Genetics Board of Directors. Points to consider: ethical, legal, and psychosocial implications of genetic testing in children and adolescents","volume":"57","author":"American Society of Human Genetics Board of Directors","year":"1995","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.pcl.2015.03.009_bib9","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1542\/peds.106.S2.389","article-title":"Serving the family from birth to the medical home: newborn screening: a blueprint for the future. A call for a national agenda on state newborn screening programs","volume":"106","author":"Newborn Screening Task Force","year":"2000","journal-title":"Pediatrics"},{"key":"10.1016\/j.pcl.2015.03.009_bib10","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1542\/peds.107.6.1451","article-title":"Ethical issues with genetic testing in pediatrics","volume":"107","author":"American Academy of Pediatrics","year":"2001","journal-title":"Pediatrics"},{"key":"10.1016\/j.pcl.2015.03.009_bib11","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1542\/peds.2012-3680","article-title":"Policy statement ethical and policy issues in genetic testing and screening of children","volume":"131","author":"American Academy of Pediatrics Committee on Bioethics","year":"2013","journal-title":"Pediatrics"},{"key":"10.1016\/j.pcl.2015.03.009_bib12","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/gim.2012.176","article-title":"Ethical and policy issues in genetic testing and screening of children","volume":"15","author":"Ross","year":"2013","journal-title":"Genet Med"},{"key":"10.1016\/j.pcl.2015.03.009_bib13","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.nmd.2013.05.008","article-title":"195th ENMC international workshop: newborn screening for Duchenne muscular dystrophy 14\u201316th December, 2012, Naarden, The Netherlands","volume":"23","author":"Ellis","year":"2013","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.pcl.2015.03.009_bib14","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1136\/adc.54.5.362","article-title":"Creatine phosphokinase levels in the newborn and their use in screening for Duchenne muscular dystrophy","volume":"54","author":"Drummond","year":"1979","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.pcl.2015.03.009_bib15","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/ana.23528","article-title":"Evidence-based path to newborn screening for Duchenne muscular dystrophy","volume":"71","author":"Mendell","year":"2012","journal-title":"Ann Neurol"},{"key":"10.1016\/j.pcl.2015.03.009_bib16","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1399-0004.1989.tb03363.x","article-title":"A\u00a0survey of manifesting carriers of Duchenne and Becker muscular dystrophy in Wales","volume":"36","author":"Norman","year":"1989","journal-title":"Clin Genet"},{"key":"10.1016\/j.pcl.2015.03.009_bib17","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S0960-8966(99)00018-8","article-title":"Cardiac involvement in carriers of Duchenne and Becker muscular dystrophy","volume":"9","author":"Hoogerwaard","year":"1999","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.pcl.2015.03.009_bib18","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S1474-4422(09)70272-8","article-title":"Diagnosis and management of Duchenne muscular dystrophy, part 2: implementation of multidisciplinary care","volume":"9","author":"Bushby","year":"2010","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.pcl.2015.03.009_bib19","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.pediatrneurol.2013.07.022","article-title":"Corticosteroid therapy for Duchene muscular dystrophy: improvement of psychomotor function","volume":"50","author":"Sato","year":"2014","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.pcl.2015.03.009_bib20","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1001\/jama.1982.03320290024023","article-title":"Diagnostic delay in Duchenne\u2019s muscular dystrophy","volume":"247","author":"Crisp","year":"1982","journal-title":"JAMA"},{"key":"10.1016\/j.pcl.2015.03.009_bib21","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/S0140-6736(98)05279-9","article-title":"Failure of early diagnosis in symptomatic Duchenne muscular dystrophy","volume":"353","author":"Bushby","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.pcl.2015.03.009_bib22","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/mus.23810","article-title":"Report of MDA muscle disease symposium on newborn screening for Duchenne muscular dystrophy","volume":"48","author":"Mendell","year":"2013","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.pcl.2015.03.009_bib23","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1038\/ejhg.2012.301","article-title":"Newborn bloodspot screening for Duchenne muscular dystrophy: 21 years experience in Wales (UK)","volume":"21","author":"Moat","year":"2013","journal-title":"Eur J Hum Genet"},{"issue":"5","key":"10.1016\/j.pcl.2015.03.009_bib24","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.2307\/3527746","article-title":"Special supplement: the disability rights critique of prenatal genetic testing reflections and recommendations","volume":"29","author":"Parens","year":"1999","journal-title":"Hastings Cent Rep"},{"key":"10.1016\/j.pcl.2015.03.009_bib25","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/ejhg.2010.13","article-title":"Reconsidering reproductive benefit through newborn screening: a systematic review of guidelines on preconception, prenatal and newborn screening","volume":"18","author":"Bombard","year":"2010","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.pcl.2015.03.009_bib26","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1542\/peds.2005-0553","article-title":"From public health emergency to public health service: the implications of evolving criteria for newborn screening panels","volume":"117","author":"Grosse","year":"2006","journal-title":"Pediatrics"},{"key":"10.1016\/j.pcl.2015.03.009_bib27","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1001\/jamapediatrics.2014.2465","article-title":"Universal state newborn screening programs can reduce health disparities","volume":"169","author":"Brosco","year":"2015","journal-title":"JAMA Pediatr"},{"key":"10.1016\/j.pcl.2015.03.009_bib28","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1002\/ajmg.a.31165","article-title":"Screening for conditions that do not meet the Wilson and Jungner criteria: the case of Duchenne muscular dystrophy","volume":"140A","author":"Ross","year":"2006","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.pcl.2015.03.009_bib29","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.pediatrneurol.2012.02.023","article-title":"Later onset phenotypes of Krabbe disease: results of the world-wide registry","volume":"46","author":"Duffner","year":"2012","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.pcl.2015.03.009_bib30","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.pediatrneurol.2011.05.007","article-title":"Early infantile Krabbe disease: results of the World-Wide Krabbe Registry","volume":"45","author":"Duffner","year":"2011","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.pcl.2015.03.009_bib31","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.pediatrneurol.2008.08.011","article-title":"The hunter\u2019s hope Krabbe family database","volume":"40","author":"Duffner","year":"2009","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.pcl.2015.03.009_bib32","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1093\/phe\/phs033","article-title":"The ethics of Krabbe newborn screening","volume":"6","author":"Dees","year":"2013","journal-title":"Publ Health Ethics"},{"key":"10.1016\/j.pcl.2015.03.009_bib33","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/s10545-011-9435-0","article-title":"Newborn screening for lysosomal storage diseases: an ethical and policy analysis","volume":"35","author":"Ross","year":"2012","journal-title":"J\u00a0Inherit Metab Dis"},{"key":"10.1016\/j.pcl.2015.03.009_bib34","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1097\/GIM.0b013e3181a16e04","article-title":"The long term outcomes of presymptomatic infants transplanted for Krabbe disease: report of the workshop held July 11 and 12, 2008, Holiday Valley, New York","volume":"11","author":"Duffner","year":"2009","journal-title":"Genet Med"},{"key":"10.1016\/j.pcl.2015.03.009_bib35","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/0387-7604(94)90013-2","article-title":"Pathological and biochemical studies of fetal Krabbe disease","volume":"16","author":"Ida","year":"1994","journal-title":"Brain Dev"},{"key":"10.1016\/j.pcl.2015.03.009_bib36","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1002\/ajmg.1320210420","article-title":"Krabbe disease: increased incidence in a highly inbred community","volume":"21","author":"Zlotogora","year":"1985","journal-title":"Am J Med Genet"},{"issue":"4","key":"10.1016\/j.pcl.2015.03.009_bib37","first-page":"196","article-title":"Krabbe disease in Israel","volume":"27","author":"Zlotogora","year":"1991","journal-title":"Isr J Med Sci"},{"key":"10.1016\/j.pcl.2015.03.009_bib38","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1002\/ajmg.a.33815","article-title":"Genetic screening for Krabbe disease: learning from the past and looking to the future","volume":"155A","author":"Macarov","year":"2011","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.pcl.2015.03.009_bib39","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1097\/GIM.0b013e3181e85721","article-title":"Weighing the evidence for newborn screening for early-infantile Krabbe disease","volume":"12","author":"Kemper","year":"2010","journal-title":"Genet Med"},{"key":"10.1016\/j.pcl.2015.03.009_bib40","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1093\/phe\/pht008","article-title":"The sad story of newborn screening for Krabbe: the need for good governance","volume":"6","author":"Miller","year":"2013","journal-title":"Publ Health Ethics"},{"key":"10.1016\/j.pcl.2015.03.009_bib41","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1093\/phe\/pht009","article-title":"Krabbe newborn screening: the issue of informed consent","volume":"6","author":"Nijsingh","year":"2013","journal-title":"Publ Health Ethics"},{"key":"10.1016\/j.pcl.2015.03.009_bib42","article-title":"EMQN best practice guidelines for the molecular genetic testing and reporting of fragile X syndrome and other fragile X-associated disorders","author":"Biancalana","year":"2014","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.pcl.2015.03.009_bib43","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1007\/s10897-012-9524-8","article-title":"Genetic counseling and testing for FMR1 gene mutations: practice guidelines of the national society of genetic counselors","volume":"21","author":"Finucane","year":"2012","journal-title":"J\u00a0Genet Couns"},{"key":"10.1016\/j.pcl.2015.03.009_bib44","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1038\/ejhg.2009.51","article-title":"Penetrance of FMR1 premutation associated pathologies in fragile X syndrome families","volume":"17","author":"Rodriguez-Revenga","year":"2009","journal-title":"Eur J Hum Genet"},{"issue":"3","key":"10.1016\/j.pcl.2015.03.009_bib45","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1001\/jamaneurol.2013.4808","article-title":"Newborn screening for fragile X syndrome","volume":"71","author":"Tassone","year":"2014","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.pcl.2015.03.009_bib46","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s10897-007-9099-y","article-title":"Recommendations from multi-disciplinary focus groups on cascade testing and genetic counseling for fragile X-associated disorders","volume":"16","author":"McConkie-Rosell","year":"2007","journal-title":"J\u00a0Genet Couns"},{"key":"10.1016\/j.pcl.2015.03.009_bib47","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/gim.2013.61","article-title":"ACMG Standards and Guidelines for fragile X testing: a revision to the disease-specific supplements to the standards and guidelines for clinical genetics laboratories of the American College of Medical Genetics and Genomics","volume":"15","author":"Monaghan","year":"2013","journal-title":"Genet Med"},{"key":"10.1016\/j.pcl.2015.03.009_bib48","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1002\/ajmg.a.33122","article-title":"\u201cIt's something I need to consider\u201d: decisions about carrier screening for fragile X syndrome in a population of non-pregnant women","volume":"149A","author":"Archibald","year":"2009","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.pcl.2015.03.009_bib49","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1002\/ajmg.a.32725","article-title":"Fragile X screening: attitudes of genetic health professionals","volume":"149A","author":"Acharya","year":"2009","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.pcl.2015.03.009_bib50","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1097\/GIM.0b013e3181e38fb6","article-title":"A\u00a0systematic review of population screening for fragile X syndrome","volume":"12","author":"Hill","year":"2010","journal-title":"Genet Med"},{"key":"10.1016\/j.pcl.2015.03.009_bib51","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1097\/AOG.0b013e3181fae884","article-title":"ACOG Committee Opinion No. 469: carrier screening for fragile X syndrome","volume":"116","author":"American College of Obstetricians and Gynecologists Committee on Genetics","year":"2010","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.pcl.2015.03.009_bib52","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1097\/01.GIM.0000182468.22666.dd","article-title":"ACMG practice guidelines: fragile X syndrome; diagnostic and carrier testing","volume":"7","author":"Sherman","year":"2005","journal-title":"Genet Med"},{"key":"10.1016\/j.pcl.2015.03.009_bib53","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/ajmg.a.35752","article-title":"Maternal attitudes to newborn screening for fragile X syndrome","volume":"161A","author":"Christie","year":"2013","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.pcl.2015.03.009_bib54","doi-asserted-by":"crossref","first-page":"e1455","DOI":"10.1542\/peds.2010-3078","article-title":"Parents' decisions to screen newborns for FMR1 gene expansions in a pilot research project","volume":"127","author":"Skinner","year":"2011","journal-title":"Pediatrics"},{"unstructured":"NIH Awards up to $25M over Five Years to Teams Testing Genome Sequencing in Newborn Screening. Available at: http:\/\/www.genomeweb.com\/sequencing\/nih-awards-25m-over-five-years-teams-testing-genome-sequencing-newborn-screening. Accessed September 4, 2013.","key":"10.1016\/j.pcl.2015.03.009_bib55"},{"doi-asserted-by":"crossref","unstructured":"Hayden EC. Is the $1,000 genome for real? Nature News http:\/\/dx.doi.org\/10.1038\/nature.2014.14530. Accessed January 15, 2014.","key":"10.1016\/j.pcl.2015.03.009_bib56","DOI":"10.1038\/nature.2014.14530"},{"issue":"11","key":"10.1016\/j.pcl.2015.03.009_bib57","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/gm205","article-title":"The $1,000 genome, the $100,000 analysis?","volume":"2","author":"Mardis","year":"2010","journal-title":"Genome Med"},{"key":"10.1016\/j.pcl.2015.03.009_bib58","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/gim.2013.76","article-title":"Parents\u2019 interest in whole-genome sequencing of newborns","volume":"16","author":"Goldenberg","year":"2014","journal-title":"Genet Med"},{"key":"10.1016\/j.pcl.2015.03.009_bib59","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1038\/ejhg.2014.22","article-title":"Public views on participating in newborn screening using genome sequencing","volume":"22","author":"Bombard","year":"2014","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.pcl.2015.03.009_bib60","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1007\/s10897-014-9706-7","article-title":"Genomic counseling in the newborn period: experiences and views of genetic counselors","volume":"23","author":"Nardini","year":"2014","journal-title":"J\u00a0Genet Couns"},{"key":"10.1016\/j.pcl.2015.03.009_bib61","doi-asserted-by":"crossref","first-page":"e903","DOI":"10.1542\/peds.2014-1839","article-title":"Comprehensive evaluation of the child with intellectual disability or global developmental delays","volume":"134","author":"Moeschler","year":"2014","journal-title":"Pediatrics"}],"container-title":["Pediatric Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031395515000292?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031395515000292?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,5,4]],"date-time":"2022-05-04T14:40:17Z","timestamp":1651675217000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031395515000292"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":61,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["S0031395515000292"],"URL":"https:\/\/doi.org\/10.1016\/j.pcl.2015.03.009","relation":{},"ISSN":["0031-3955"],"issn-type":[{"type":"print","value":"0031-3955"}],"subject":[],"published":{"date-parts":[[2015,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ethical and Policy Issues in Newborn Screening of Children for Neurologic and Developmental Disorders","name":"articletitle","label":"Article Title"},{"value":"Pediatric Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pcl.2015.03.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}